Navigation Links
Barry D. Rutherford, M.D. presented with Master Clinical Operator Award at TCT 2012
Date:10/26/2012

MIAMI, FL OCTOBER 26, 2012 Barry D. Rutherford, MD, a world renowned interventional cardiologist, was presented the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and innovation.

An early mentor of Dr. Hartzler at the Mayo Clinic in Rochester, Minnesota, and later a colleague of his at the Saint Luke's Mid America Heart Institute in Kansas City, Missouri, Dr. Rutherford is known for his expertise in the development of techniques for direct balloon angioplasty in acute myocardial infarction and multi-vessel angioplasty. Among his current research interests are the development of new procedures for the treatment of chronic total occlusions in coronary arteries and for the management of acute myocardial infarction.

Dr. Rutherford has also devoted much of his career to physician training and education, teaching countless numbers of physicians over the years. In addition to serving as the principal investigator of a number of clinical trials, Dr. Rutherford has authored more than 200 abstracts and publications in peer reviewed journals and has delivered more than 230 invited lectures around the world.

TCT Directors, Gregg W. Stone, MD and Martin B. Leon, MD jointly presented the award, which recognizes technical skill and expertise. Dr. Leon is the Founder of CRF and Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Stone is Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Both serve as Co-Directors of the Medical Research and Education Division at CRF, and direct the annual TCT scientific sessions.

"Dr. Rutherford is highly deserving of the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award," said Dr. Stone. "His long-standing commitment to primary PCI and multivessel intervention, and technical expertise in CTO angioplasty have helped to expand the field of interventional cardiovascular medicine and provided physicians with new, more effective ways to treat patients."

"Dr. Rutherford continues to develop innovative techniques and devices for patients with cardiovascular disease, in addition to serving as mentor and teacher to the next generation of interventional cardiologists," Dr. Leon added.

Dr. Rutherford is currently the Director of the Interventional Cardiology Research Program at St. Luke's Mid America Heart Institute in Kansas City, Missouri. He is also a Professor of Medicine at the University of Missouri in Kansas City. Prior to his current position, Dr. Rutherford was consulting cardiologist at the Mayo Clinic, and Director of the Coronary Care Unit at St. Mary's Hospital in Rochester, Minnesota where he initiated research into pulmonary artery pressure during acute myocardial infarction and computer assisted patient records in the intensive care unit.

Dr. Rutherford earned his medical degree at Otago University Medical School (Dunedin, New Zealand) in 1963 and completed his residency training at the Mayo Graduate School of Medicine and Mayo Foundation for Cardiovascular Diseases.


'/>"/>
Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Renu Virmani, M.D. presented with 2012 TCT Career Achievement Award
2. Results of the AIDA STEMI MRI sub-study presented at TCT 2012
3. Results of the PC trial presented at TCT 2012
4. Results of the POSEIDON trial presented at TCT 2012
5. 1-year results of ADAPT-DES presented at TCT 2012
6. CRF announces late breaking trials and first report investigations to be presented at TCT 2012
7. New clinical guidelines for managing hypothyroid disease presented in Thyroid Journal
8. Research presented at TCT 2012 will have significant impact on interventional cardiology
9. Typical IBD patients not represented in research studies
10. Robotic surgery outcomes data presented at head and neck cancer annual meeting
11. Special issue of Cell Transplantation features research presented at IANR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... Grocery Company to the list of fine retailers selling biodegradable, hanging flushable wipes ... H.E.B., a large supermarket chain headquartered in San Antonio, Texas, operates more than ...
(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation Commission for Health Care ... of America (HCAOA). This agreement allows HCAOA members to receive special pricing on ... on Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC ...
(Date:4/28/2017)... ... April 28, 2017 , ... Getting enough sleep affects much more than energy – ... just 19 hours without sleep can compromise motor reaction time, which can increase the risk ... Insurance is sharing the following tips from the NSF to help you sleep better and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back ... joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified ... The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike ...
(Date:4/28/2017)... MA (PRWEB) , ... April 28, 2017 , ... People ... for older people. “Wearing a hearing aid doesn’t have the stigma it had when ... & Hearing Associates of Greater Boston, in a NALA North American Speaker Series ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... 18, 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), ... Urology, Uro/Gyn and Gynecology markets with innovative and proprietary ... ended March 31, 2017 after the market close on ... will host a conference call and webcast to discuss ... 2, 2017 at 4:30 p.m. Eastern Time (3:30 p.m. ...
Breaking Medicine Technology: